The effectiveness of preemptive sphenopalatine ganglion block on postoperative pain and functional outcomes after functional endoscopic sinus surgery

2011 ◽  
Vol 1 (3) ◽  
pp. 212-218 ◽  
Author(s):  
Do-Yeon Cho ◽  
David R. Drover ◽  
Vladimir Nekhendzy ◽  
Alexander J. Butwick ◽  
Jeremy Collins ◽  
...  
Keyword(s):  
Postoperative Pain ◽  
Endoscopic Sinus Surgery ◽  
Functional Outcomes ◽  
Functional Endoscopic Sinus Surgery ◽  
Sinus Surgery ◽  
Sphenopalatine Ganglion ◽  
Ganglion Block ◽  
Sphenopalatine Ganglion Block

scholarly journals Effect of Sphenopalatine Ganglion Block With Bupivacaine on Postoperative Pain in Patients Undergoing Endoscopic Sinus Surgery

2019 ◽  
Vol 10 ◽  
pp. 215265671882128 ◽  
Author(s):  
Ahmad Rezaeian ◽  
Seyed Mostafa Hashemi ◽  
Zeinab Sadat Dokhanchi
Keyword(s):  
Postoperative Pain ◽  
Endoscopic Sinus Surgery ◽  
Intervention Group ◽  
Sinus Surgery ◽  
Control Group ◽  
Sphenopalatine Ganglion ◽  
Ganglion Block ◽  
Rescue Analgesia ◽  
Sphenopalatine Ganglion Block ◽  
And Control

Background Postoperative pain is one of the most complications in endoscopic sinus surgery. We aimed to evaluate the effect of the sphenopalatine ganglion block (SPGB) with bupivacaine on postoperative pain in patients undergoing endoscopic sinus surgery. Methods and Materials: In this clinical trial, 40 patients who indicated functional endoscopic sinus surgery were selected and then divided into 2 parallel groups as intervention and control. The intervention group was received 1.5 mL of bupivacaine 0.5% (injected to sphenopalatine ganglion) and while control was injected 1.5 mL of normal saline at the same injection site. Also, the visual analogue scale (VAS) was recorded immediately after anesthesia, along with 6, 12, 24, 48 h, 7 days, and 21 days after the operation for all patients. Results Immediately after anesthesia, as well as 6, 12, and 24 h after the operation, VAS in the intervention group was significantly lower than in the control group ( P < .05, for all). However, there were no significant differences between the 2 groups regarding VAS 48 h as well as 7 and 21 days after surgery ( P > .05, for both). Also, the rescue analgesia in the intervention group was significantly lower than in the control group ( P = .01). Conclusion SPGB with bupivacaine 0.5% (1.5 mL) was a simple, effective, safe, and noninvasive method for the management of postoperative pain in the patients undergoing endoscopic sinus surgery.

Sign in / Sign up

Export Citation Format

Share Document